Combined Ala601-Thr-type dysplasminogenaemia and antiphospholipid antibody syndrome in a patient with recurrent thrombosis

Thrombosis Research

Volumn 105, Issue 6, 2002, Pages 513-517

  Iguchi, Seitaro ^a   Kazama, J James ^a   Ito, Satoshi ^a   Shimada, Hisaki ^a   Nishi, Shinichi ^a   Gejyo, Fumitake ^a   Higuchi, Wataru ^b   Fuse, Ichiro ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Antiphospholipid antibody syndrome; Congenital dysplasminogenaemia; Plasminogen Tochigi; SLE

Indexed keywords

ANTIGEN; PLASMINOGEN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DYSPLASMINOGENEMIA; EXON; FAMILIAL DISEASE; GENETIC ANALYSIS; HUMAN; MALE; MISSENSE MUTATION; PHOSPHOLIPID ANTIBODY SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; RECURRENT DISEASE; RISK FACTOR; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ANTIPHOSPHOLIPID SYNDROME; BLOOD; BLOOD CLOTTING; FAMILY HEALTH; GENETICS; HOMOZYGOTE; NUCLEOTIDE SEQUENCE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; BLOOD COAGULATION; CASE REPORT; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; HOMOZYGOTE; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MUTATION, MISSENSE; PLASMINOGEN; RECURRENCE; RISK FACTORS; THROMBOSIS; HUMANS;

EID: 0037085701     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00055-5     Document Type: Article

References (29)

1. The plasminogen-plasmin enzyme system
2. Type I congenital plasminogen deficiency is not a risk factor for thrombosis
3. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis
4. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis; A statistic analysis in 20 kindreds
5. The 1982 revised criteria for the classification of systemic lupus erythematosus
6. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
7. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation
8. Criteria for the diagnosis of lupus anticoagulants: An update
9. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop
10. Plasminogen Tochigi: Inactive plasmin resulting from replacement of alanine-600 by threonine in the active site
11. Two types of abnormal genes for plasminogen in families with predisposition for thrombosis
12. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis
13. Molecular abnormality of plasminogen
14. Plasminogen Kanagawa-I, a novel missense mutation, is caused by the amino acid substitution G732R
15. Genetic abnormalities of the fibrinolytic system
16. Severe thrombotic tendency with a type I plasminogen deficiency
17. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency
18. Abnormal plasminogen, a case of recurrent thrombosis
19. Thrombovascular disease and familial plasminogen deficiency: A report of three kindreds
20. Congenital deficiency of plasminogen and its relationship to venous thrombosis
21. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
22. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: Results of the Spanish Multicentric Study on Thrombophilia (EMET study)
23. Is plasminogen deficiency a thrombotic risk factor? - A study on 23 thrombophilic patients and their family members
24. Transient ischemic attacks in two sisters with plasminogen deficiency and factor V Leiden
25. Familial dysplasminogenaemia with central retinal vein and cilioretinal artery occlusion
26. Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and Factor V R506Q mutation
27. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus
28. Antiphospholipid antibodies and venous thromboembolism
29. Deep venous thrombosis and lupus anticoagulant. A case-control study